Skip to content

The effect of scent and glucose on pain of neonates

Comparison of the effect of familiar olfactory stimulation (lavender scent) and glucose on pain from blood sampling in term neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015010220529N1
Enrollment
120
Registered
2015-02-16
Start date
2012-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain. pain not referable to any one organ or body region

Interventions

Intervention 1: Without receipt specific intervention for pain, blood samples were taken. Intervention 2: Infants at night for 8 hours before blood sampling were exposed to the scent of lavender. And
Treatment - Other
Without receipt specific intervention for pain, blood samples were taken.
Infants at night for 8 hours before blood sampling were exposed to the scent of lavender. And the next day, at the time of blood sampling was used of the scent of lavender.
Infants 2 minutes before the taking blood sample received 2 cc edible glucose 30%

Sponsors

Vice chancellor for research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Days to 13 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: a- Gestational age over 37 weeks, b- Appearance, Pulse, Grimace, Activity, Respiration (APGAR) scores at five minutes greater than seven c- Non-use of tranquilizer or sedative and anticonvulsant drug during the last 24 hours by mother and neonate d- Need for venous blood sampling e- Stability in general and clinical status f- Oral feeding is not prohibited g- The mother has not received any opioid i- Lack of Diabetes in the mother. Exclusion criteria: a- If the baby in the familiar scent group, should be taken blood sampling during the orientation phase. b- If the infants in the familiar scent group, during the familiar within scent up to blood sampling, was discharged or to cause any complications or problems that interfere with the natural trend of neonatal care, orientation phase stop. c- If the infant receive milk or any sugar within thirty minutes prior to the start of the blood sampling. d- If the infant is restless and uneasy before blood sampling. e- If the first attempt for blood sampling was not successful.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Immediately after the entry of the needle into the vein. Method of measurement: Pain assessment scale scores Douleur Aigue Nouveau-ne (DAN).The scale is used to evaluate 3 items: facial expressions, limb movements and vocal expression.

Secondary

MeasureTime frame
The duration of crying. Timepoint: According to seconds, in 3 minutes at the beginning of the blood sampling was measured. Method of measurement: Stopwatch.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNaghmeh Razaghi

Mashhad University of Medical Sciences

razaghin@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026